Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure have?
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure has 285 citations in the OpenAlex counts ScholarIQ stores.
When was Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure published?
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure has 2021 year in the ScholarIQ index.
What is the open-access status of Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure?
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure has bronze oa status in the ScholarIQ index.
What is the DOI of Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure?
The DOI for Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure is on the source record.
What is the PMID of Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure?
The PMID for Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure is on the source record.
What is the OpenAlex record for Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure?
The OpenAlex for Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure is on the source record.